Trial Activity Snapshot: Did Australia’s “zero-Covid” plan protect clinical trial activity?
In an exclusive, Clinical Trials Arena dives into Australia’s trial activity data to find out how the pandemic impacted the…
By
Drug Development
Latest in
Drug Development
Sensorion’s sudden sensorineural hearing loss asset fails Phase II test
The asset failed to meet the primary goal of 15 decibels, a substantial improvement in pure tone audiometry in the…
Pipeline Moves: J&J ends ulcerative colitis trial, further study chances drop
Clinical Trials Arena reviews a total of six trials, including ones in gram-negative bacterial infections, hepatitis B, and obesity.
By
Moderna eyes combined Covid-19, flu booster by 2023
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
By
George Medicines to analyse three-in-one hypertension pill in UK trial
The trial will assess the efficacy and safety of GMRx2 against dual cocktails of the same components for 12 weeks.
Clinical trial diversity: It’s time to quit talking and start doing
In order to improve diversity in trials, inequities due to economic factors and race need to be bridged at institutional…
By
Numinus seeks Health Canada approval to start psychedelic product trial
The autonomous, two-phased trial HOPE will be conducted at a Numinus clinic in Vancouver, Canada.
Burden of brain cancer will continue to rise in the US ageing population
GlobalData epidemiologists forecast that more than half of all newly diagnosed cases in the US are in the age 60…
By